Status:

UNKNOWN

Oxidized LDL With Oxygen Therapy in Acute Coronary Syndrome.

Lead Sponsor:

Assiut University

Conditions:

Acute Coronary Syndrome

Eligibility:

All Genders

18-60 years

Brief Summary

Coronary artery disease (CAD) is increasing rapidly in Egyptian people and manifesting a younger age. Higher plasma low-density lipoprotein cholesterol (LDL-C), is a major predictor for the developmen...

Detailed Description

Cardiovascular disease, which is multifactorial and caused by complex interactions of genetic and environmental factors, represents the main cause of death all over the world. Traditional risk factors...

Eligibility Criteria

Inclusion

  • Patients were included irrespective of concomitant risk factors for atherosclerosis such as smoking, arterial hypertension and diabetes mellitus.
  • Participants were both sexes.

Exclusion

  • Congenital heart disease.
  • Dilated, hypertrophic or restrictive cardiomyopathy.
  • acute and chronic liver disorders.

Key Trial Info

Start Date :

February 20 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2019

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT03830138

Start Date

February 20 2019

End Date

May 1 2019

Last Update

February 5 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Oxidized LDL With Oxygen Therapy in Acute Coronary Syndrome. | DecenTrialz